264 related articles for article (PubMed ID: 38520648)
1. 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment.
Zhang Z; Chen X; Gao S; Fang X; Ren S
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38520648
[TBL] [Abstract][Full Text] [Related]
2. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
[TBL] [Abstract][Full Text] [Related]
3. 3D bioprinting of gastrointestinal cancer models: A comprehensive review on processing, properties, and therapeutic implications.
Prashantha K; Krishnappa A; Muthappa M
Biointerphases; 2023 Mar; 18(2):020801. PubMed ID: 36963961
[TBL] [Abstract][Full Text] [Related]
4. 3D modeling of normal skin and cutaneous squamous cell carcinoma. A comparative study in 2D cultures, spheroids, and 3D bioprinted systems.
Kurzyk A; Szumera-Ciećkiewicz A; Miłoszewska J; Chechlińska M
Biofabrication; 2024 Feb; 16(2):. PubMed ID: 38377605
[TBL] [Abstract][Full Text] [Related]
5. Deployable extrusion bioprinting of compartmental tumoroids with cancer associated fibroblasts for immune cell interactions.
Mazzaglia C; Sheng Y; Rodrigues LN; Lei IM; Shields JD; Huang YYS
Biofabrication; 2023 Jan; 15(2):. PubMed ID: 36626838
[TBL] [Abstract][Full Text] [Related]
6. 3D bioprinting complex models of cancer.
Sharma R; Restan Perez M; da Silva VA; Thomsen J; Bhardwaj L; Andrade TAM; Alhussan A; Willerth SM
Biomater Sci; 2023 May; 11(10):3414-3430. PubMed ID: 37000528
[TBL] [Abstract][Full Text] [Related]
7. Application of three-dimensional (3D) bioprinting in anti-cancer therapy.
Wu BX; Wu Z; Hou YY; Fang ZX; Deng Y; Wu HT; Liu J
Heliyon; 2023 Oct; 9(10):e20475. PubMed ID: 37800075
[TBL] [Abstract][Full Text] [Related]
8. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
Jung M; Ghamrawi S; Du EY; Gooding JJ; Kavallaris M
Adv Healthc Mater; 2022 Dec; 11(24):e2200690. PubMed ID: 35866252
[TBL] [Abstract][Full Text] [Related]
9. Correction to: 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment.
Zhang Z; Chen X; Gao S; Fang X; Ren S
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38687444
[No Abstract] [Full Text] [Related]
10. 3D bioprinted tumor model with extracellular matrix enhanced bioinks for nanoparticle evaluation.
Chen Y; Xu L; Li W; Chen W; He Q; Zhang X; Tang J; Wang Y; Liu B; Liu J
Biofabrication; 2022 Jan; 14(2):. PubMed ID: 34991080
[TBL] [Abstract][Full Text] [Related]
11. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
12. Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine.
Kim J; Jang J; Cho DW
Micromachines (Basel); 2021 Sep; 12(9):. PubMed ID: 34577765
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer models: Engineering the tumor microenvironment.
Bahcecioglu G; Basara G; Ellis BW; Ren X; Zorlutuna P
Acta Biomater; 2020 Apr; 106():1-21. PubMed ID: 32045679
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
15. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
16. Can 3D bioprinting solve the mystery of senescence in cancer therapy?
Shboul SA; DeLuca VJ; Dweiri YA; Saleh T
Ageing Res Rev; 2022 Nov; 81():101732. PubMed ID: 36100069
[TBL] [Abstract][Full Text] [Related]
17. Recapitulating Tumorigenesis
Kronemberger GS; Miranda GASC; Tavares RSN; Montenegro B; Kopke ÚA; Baptista LS
Front Bioeng Biotechnol; 2021; 9():682498. PubMed ID: 34239860
[TBL] [Abstract][Full Text] [Related]
18. 3D printing to construct in vitro multicellular models of melanoma.
Sang S; Wang X; Duan J; Cao Y; Shen Z; Sun L; Duan Q; Liu Z
Biotechnol Bioeng; 2023 Oct; 120(10):2853-2864. PubMed ID: 37227037
[TBL] [Abstract][Full Text] [Related]
19. 3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.
Mollica PA; Booth-Creech EN; Reid JA; Zamponi M; Sullivan SM; Palmer XL; Sachs PC; Bruno RD
Acta Biomater; 2019 Sep; 95():201-213. PubMed ID: 31233891
[TBL] [Abstract][Full Text] [Related]
20. 3D Bioprinting of Tumor Models for Cancer Research.
Kang Y; Datta P; Shanmughapriya S; Ozbolat IT
ACS Appl Bio Mater; 2020 Sep; 3(9):5552-5573. PubMed ID: 35021789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
